Start free

Acrivon Therapeutics, Inc. (ACRV) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 19, 2026.

Filings shown
43
Open-market buys
0
Open-market sells
17

Counts cover the 43 most recent Form 4 filings Tradune holds for ACRV (filed May 18 – Nov 19, 2026); the score below covers only the trailing 90 days (0 buys, 9 sells). SEC EDGAR Form 4 filings for ACRV last checked Nov 21, 2026, 09:00 UTC; the latest ACRV filing Tradune holds was filed Nov 19, 2026. This is not guaranteed to be the complete record — see ACRV's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 9 filings Tradune holds for ACRV filed Aug 27 – Nov 19, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

9 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
9 sales· 17,967 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Peter Blume-JensenPresident and CEO 0 3 — 15,816 −$33,550
Mary MillerChief Legal Officer 0 3 — 1,000 −$1,809
Eric DevroeChief Operating Officer 0 1 — 628 −$911
Erick GamelinChief Development Officer 0 1 — 416 −$603
Katharine PetersonChief Accounting Officer 0 1 — 107 −$155

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 9 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ACRV

No open-market insider purchases (Form 4 code P) were reported for ACRV between May 18, 2026 and Nov 19, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Katharine Peterson Chief Accounting Officer · filed Nov 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 107 $1.45 17,926 −0.6% Nov 17, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Mary Miller Chief Legal Officer · filed Nov 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 193 $1.45 81,009 −0.2% Nov 17, 2026
Erick Gamelin Chief Development Officer · filed Nov 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 416 $1.45 52,176 −0.8% Nov 17, 2026
Eric Devroe Chief Operating Officer · filed Nov 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 628 $1.45 145,721 −0.4% Nov 17, 2026
Peter Blume-Jensen President and CEO · filed Nov 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1,276 $1.45 2,228,776 −0.1% Nov 17, 2026
Open-market sale 10b5-1 box not checked 504 $1.45 385,355 (indirect) −0.1% Nov 17, 2026
Mary Miller Chief Legal Officer · filed Oct 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 513 $1.84 81,202 −0.6% Oct 22, 2026
Mary Miller Chief Legal Officer · filed Oct 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 294 $1.99 81,715 −0.4% Oct 5, 2026
Michaela Levin Chief Business Officer · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 30,000 — 30,000 — Aug 31, 2026
Grant / award Stock Option (Right to Buy) 130,000 — — — Aug 31, 2026
Peter Blume-Jensen President and CEO · filed Aug 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 14,036 $2.21 2,230,052 −0.6% Aug 25, 2026
Katharine Peterson Chief Accounting Officer · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 101 $2.01 18,033 −0.6% Aug 18, 2026
Mary Miller Chief Legal Officer · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 185 $2.01 82,009 −0.2% Aug 18, 2026
Erick Gamelin Chief Development Officer · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 400 $2.01 52,592 −0.8% Aug 18, 2026
Eric Devroe Chief Operating Officer · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 604 $2.01 146,349 −0.4% Aug 18, 2026
Peter Blume-Jensen President and CEO · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1,229 $2.01 2,244,088 −0.1% Aug 18, 2026
Open-market sale 10b5-1 box not checked 484 $2.01 385,859 (indirect) −0.1% Aug 18, 2026
Adam D. Levy Chief Financial Officer · filed Aug 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1,142 $1.57 66,008 −1.7% Aug 4, 2026
Mary Miller Chief Legal Officer · filed Jul 23, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 573 $1.76 82,194 −0.7% Jul 21, 2026
Ra Capital Management, L.P. Director, 10% owner · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 20,275 — — — Jun 17, 2026
Michael John Tomsicek Director · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 20,275 — — — Jun 17, 2026
Sharon Shacham Director · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 20,275 — — — Jun 17, 2026
Santhosh Palani Director · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 20,275 — — — Jun 17, 2026
Ivana Magovcevic-Liebisch Director · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 20,275 — — — Jun 17, 2026
Derek DiRocco Director · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 20,275 — — — Jun 17, 2026
Charles M. Baum Director · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 20,275 — — — Jun 17, 2026
Peter Blume-Jensen President and CEO · filed May 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 13,729 $1.79 2,245,317 −0.6% May 21, 2026
Ra Capital Management, L.P. Director, 10% owner · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 9,366 — 9,366 (indirect) — May 18, 2026

Listing the 25 most recent of 43 Form 4 filings held for ACRV; the 18 older filings (filed May 18 – May 20, 2026) are counted above but not listed here — see ACRV's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ACRV's (Nov 19, 2026).

Frequently asked about ACRV insider activity

How many insiders bought ACRV stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of ACRV shares were reported by Acrivon Therapeutics, Inc. insiders between May 18, 2026 and Nov 19, 2026. The 43 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for ACRV?

The most recent Form 4 on this page was filed by Peter Blume-Jensen (President and CEO) on Nov 19, 2026, reporting 2 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ACRV insider sale shown?

The largest open-market sale among the filings shown was 14,036 ACRV shares at $2.21 (about $30,969) by Peter Blume-Jensen (President and CEO) on Aug 25, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ACRV — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.